Drucken

Sie suchten nach: N-alpha-BOC-D-Asparagin


46 154  Ergebnisse wurden gefunden

Suchergebnis einschränken: Sortieren nach
SearchResultCount:"46154"

Sort Results

Listenansicht Hybridansicht

Bewerten Sie das Suchergebnis

Image Unavailable-A16019.06

N-ɑ-Boc-L-asparagine ≥98%

Lieferant: Thermo Scientific
Beschreibung: N-ɑ-Boc-L-asparagine ≥98%

Sicherheitsdatenblätter Zertifikate

Image Unavailable-H61121.14

N-alpha-BOC-D-Asparagin 95%

Lieferant: Thermo Scientific
Beschreibung: N-alpha-BOC-D-Asparagin 95%

Zertifikate

Product Image-94341-100G

L(+)-Asparagin, wasserfrei ≥99,0%, hochrein

Artikel-Nr: (94341-100G)
Lieferant: VWR Chemicals
Beschreibung: Nicht tierische Aminosäure. Polar. Amid.
VE: 1 * 100 g

Sicherheitsdatenblätter Zertifikate


Product Image-15005.297

L(+)-Asparagin, wasserfrei 98,0-102,0% für die biopharmazeutische Produktion

Lieferant: VWR Chemicals
Beschreibung: L(+)-Asparagin, wasserfrei 98,0-102,0% für die biopharmazeutische Produktion

Sicherheitsdatenblätter Zertifikate

Image Unavailable-B21473.0E

L(+)-Asparagin, wasserfrei 99%

Lieferant: Thermo Scientific
Beschreibung: L(+)-Asparagin, wasserfrei 99%

Sicherheitsdatenblätter Zertifikate

Product Image-ACRO371605000

L(+)-Asparagin 99%

Lieferant: Thermo Scientific
Beschreibung: L(+)-Asparagin 99%

Sicherheitsdatenblätter

Image Unavailable-BOSSBS-13322R-FITC

Anti-MOGS Rabbit Polyclonal Antibody (FITC (Fluorescein Isothiocyanate))

Artikel-Nr: (BOSSBS-13322R-FITC)
Lieferant: Bioss
Beschreibung: Glycosylation of asparagine residues in Asn-X-Ser/Thr motifs in proteins commonly occur in the lumen of the endoplasmic reticulum (ER). Glucosidase I catalyzes the first step in the N-linked oligosaccharide processing pathway. It specifically removes the distal alpha 1,2-linked glucose residue from the Glc3-Man9-GlcNAc2 oligosaccharide precursor. Glucosidase I contains a short cytosolic tail, a single pass transmembrane domain and a large C-terminal catalytic domain located on the luminal side of the ER. Mutations in the gene encoding Glucosidase I result in the congenital disorder glycosylation (CDG-IIb), which is characterized by generalized hypotonia, dysmorphic features, hepatomegaly, hypoventilation, feeding problems, seizures and death. Two point mutations in the Glucosidase I gene have been identified and result in amino acid substitutions, namely Arg486Thr and Phe652Leu, that affect polypeptide folding and active site formation.
VE: 1 * 100 µl
Image Unavailable-BOSSBS-13322R

Anti-GCS1 Rabbit Polyclonal Antibody

Artikel-Nr: (BOSSBS-13322R)
Lieferant: Bioss
Beschreibung: Glycosylation of asparagine residues in Asn-X-Ser/Thr motifs in proteins commonly occur in the lumen of the endoplasmic reticulum (ER). Glucosidase I catalyzes the first step in the N-linked oligosaccharide processing pathway. It specifically removes the distal alpha 1,2-linked glucose residue from the Glc3-Man9-GlcNAc2 oligosaccharide precursor. Glucosidase I contains a short cytosolic tail, a single pass transmembrane domain and a large C-terminal catalytic domain located on the luminal side of the ER. Mutations in the gene encoding Glucosidase I result in the congenital disorder glycosylation (CDG-IIb), which is characterized by generalized hypotonia, dysmorphic features, hepatomegaly, hypoventilation, feeding problems, seizures and death. Two point mutations in the Glucosidase I gene have been identified and result in amino acid substitutions, namely Arg486Thr and Phe652Leu, that affect polypeptide folding and active site formation.
VE: 1 * 100 µl
Image Unavailable-BOSSBS-13322R-A750

Anti-GCS1 Rabbit Polyclonal Antibody (Alexa Fluor® 750)

Artikel-Nr: (BOSSBS-13322R-A750)
Lieferant: Bioss
Beschreibung: Glycosylation of asparagine residues in Asn-X-Ser/Thr motifs in proteins commonly occur in the lumen of the endoplasmic reticulum (ER). Glucosidase I catalyzes the first step in the N-linked oligosaccharide processing pathway. It specifically removes the distal alpha 1,2-linked glucose residue from the Glc3-Man9-GlcNAc2 oligosaccharide precursor. Glucosidase I contains a short cytosolic tail, a single pass transmembrane domain and a large C-terminal catalytic domain located on the luminal side of the ER. Mutations in the gene encoding Glucosidase I result in the congenital disorder glycosylation (CDG-IIb), which is characterized by generalized hypotonia, dysmorphic features, hepatomegaly, hypoventilation, feeding problems, seizures and death. Two point mutations in the Glucosidase I gene have been identified and result in amino acid substitutions, namely Arg486Thr and Phe652Leu, that affect polypeptide folding and active site formation.
VE: 1 * 100 µl
Image Unavailable-BOSSBS-13322R-A647

Anti-MOGS Rabbit Polyclonal Antibody (Alexa Fluor® 647)

Artikel-Nr: (BOSSBS-13322R-A647)
Lieferant: Bioss
Beschreibung: Glycosylation of asparagine residues in Asn-X-Ser/Thr motifs in proteins commonly occur in the lumen of the endoplasmic reticulum (ER). Glucosidase I catalyzes the first step in the N-linked oligosaccharide processing pathway. It specifically removes the distal alpha 1,2-linked glucose residue from the Glc3-Man9-GlcNAc2 oligosaccharide precursor. Glucosidase I contains a short cytosolic tail, a single pass transmembrane domain and a large C-terminal catalytic domain located on the luminal side of the ER. Mutations in the gene encoding Glucosidase I result in the congenital disorder glycosylation (CDG-IIb), which is characterized by generalized hypotonia, dysmorphic features, hepatomegaly, hypoventilation, feeding problems, seizures and death. Two point mutations in the Glucosidase I gene have been identified and result in amino acid substitutions, namely Arg486Thr and Phe652Leu, that affect polypeptide folding and active site formation.
VE: 1 * 100 µl
Image Unavailable-USBI123229

Anti-ALG12 Mouse Monoclonal Antibody [clone: 5E3]

Artikel-Nr: (USBI123229)
Lieferant: US Biological
Beschreibung: Anti-ALG12 Mouse Monoclonal Antibody [clone: 5E3]
VE: 1 * 100 µG
Image Unavailable-BOSSBS-13322R-CY7

Anti-MOGS Rabbit Polyclonal Antibody (Cy7®)

Artikel-Nr: (BOSSBS-13322R-CY7)
Lieferant: Bioss
Beschreibung: Glycosylation of asparagine residues in Asn-X-Ser/Thr motifs in proteins commonly occur in the lumen of the endoplasmic reticulum (ER). Glucosidase I catalyzes the first step in the N-linked oligosaccharide processing pathway. It specifically removes the distal alpha 1,2-linked glucose residue from the Glc3-Man9-GlcNAc2 oligosaccharide precursor. Glucosidase I contains a short cytosolic tail, a single pass transmembrane domain and a large C-terminal catalytic domain located on the luminal side of the ER. Mutations in the gene encoding Glucosidase I result in the congenital disorder glycosylation (CDG-IIb), which is characterized by generalized hypotonia, dysmorphic features, hepatomegaly, hypoventilation, feeding problems, seizures and death. Two point mutations in the Glucosidase I gene have been identified and result in amino acid substitutions, namely Arg486Thr and Phe652Leu, that affect polypeptide folding and active site formation.
VE: 1 * 100 µl
Image Unavailable-BOSSBS-13322R-CY5

Anti-MOGS Rabbit Polyclonal Antibody (Cy5®)

Artikel-Nr: (BOSSBS-13322R-CY5)
Lieferant: Bioss
Beschreibung: Glycosylation of asparagine residues in Asn-X-Ser/Thr motifs in proteins commonly occur in the lumen of the endoplasmic reticulum (ER). Glucosidase I catalyzes the first step in the N-linked oligosaccharide processing pathway. It specifically removes the distal alpha 1,2-linked glucose residue from the Glc3-Man9-GlcNAc2 oligosaccharide precursor. Glucosidase I contains a short cytosolic tail, a single pass transmembrane domain and a large C-terminal catalytic domain located on the luminal side of the ER. Mutations in the gene encoding Glucosidase I result in the congenital disorder glycosylation (CDG-IIb), which is characterized by generalized hypotonia, dysmorphic features, hepatomegaly, hypoventilation, feeding problems, seizures and death. Two point mutations in the Glucosidase I gene have been identified and result in amino acid substitutions, namely Arg486Thr and Phe652Leu, that affect polypeptide folding and active site formation.
VE: 1 * 100 µl
Image Unavailable-BOSSBS-13322R-CY3

Anti-MOGS Rabbit Polyclonal Antibody (Cy3®)

Artikel-Nr: (BOSSBS-13322R-CY3)
Lieferant: Bioss
Beschreibung: Glycosylation of asparagine residues in Asn-X-Ser/Thr motifs in proteins commonly occur in the lumen of the endoplasmic reticulum (ER). Glucosidase I catalyzes the first step in the N-linked oligosaccharide processing pathway. It specifically removes the distal alpha 1,2-linked glucose residue from the Glc3-Man9-GlcNAc2 oligosaccharide precursor. Glucosidase I contains a short cytosolic tail, a single pass transmembrane domain and a large C-terminal catalytic domain located on the luminal side of the ER. Mutations in the gene encoding Glucosidase I result in the congenital disorder glycosylation (CDG-IIb), which is characterized by generalized hypotonia, dysmorphic features, hepatomegaly, hypoventilation, feeding problems, seizures and death. Two point mutations in the Glucosidase I gene have been identified and result in amino acid substitutions, namely Arg486Thr and Phe652Leu, that affect polypeptide folding and active site formation.
VE: 1 * 100 µl
Image Unavailable-BOSSBS-13322R-A680

Anti-GCS1 Rabbit Polyclonal Antibody (Alexa Fluor® 680)

Artikel-Nr: (BOSSBS-13322R-A680)
Lieferant: Bioss
Beschreibung: Glycosylation of asparagine residues in Asn-X-Ser/Thr motifs in proteins commonly occur in the lumen of the endoplasmic reticulum (ER). Glucosidase I catalyzes the first step in the N-linked oligosaccharide processing pathway. It specifically removes the distal alpha 1,2-linked glucose residue from the Glc3-Man9-GlcNAc2 oligosaccharide precursor. Glucosidase I contains a short cytosolic tail, a single pass transmembrane domain and a large C-terminal catalytic domain located on the luminal side of the ER. Mutations in the gene encoding Glucosidase I result in the congenital disorder glycosylation (CDG-IIb), which is characterized by generalized hypotonia, dysmorphic features, hepatomegaly, hypoventilation, feeding problems, seizures and death. Two point mutations in the Glucosidase I gene have been identified and result in amino acid substitutions, namely Arg486Thr and Phe652Leu, that affect polypeptide folding and active site formation.
VE: 1 * 100 µl
Image Unavailable-BOSSBS-13322R-HRP

Anti-MOGS Rabbit Polyclonal Antibody (HRP (Horseradish Peroxidase))

Artikel-Nr: (BOSSBS-13322R-HRP)
Lieferant: Bioss
Beschreibung: Glycosylation of asparagine residues in Asn-X-Ser/Thr motifs in proteins commonly occur in the lumen of the endoplasmic reticulum (ER). Glucosidase I catalyzes the first step in the N-linked oligosaccharide processing pathway. It specifically removes the distal alpha 1,2-linked glucose residue from the Glc3-Man9-GlcNAc2 oligosaccharide precursor. Glucosidase I contains a short cytosolic tail, a single pass transmembrane domain and a large C-terminal catalytic domain located on the luminal side of the ER. Mutations in the gene encoding Glucosidase I result in the congenital disorder glycosylation (CDG-IIb), which is characterized by generalized hypotonia, dysmorphic features, hepatomegaly, hypoventilation, feeding problems, seizures and death. Two point mutations in the Glucosidase I gene have been identified and result in amino acid substitutions, namely Arg486Thr and Phe652Leu, that affect polypeptide folding and active site formation.
VE: 1 * 100 µl
Preis auf Anfrage
Lager für diesen Artikel ist begrenzt, kann aber in einem Lagerhaus in Ihrer Nähe zur Verfügung. Bitte stellen Sie sicher, dass Sie in sind angemeldet auf dieser Seite, so dass verfügbare Bestand angezeigt werden können. Wenn das call noch angezeigt wird und Sie Hilfe benötigen, rufen Sie uns an 1-800-932 - 5000.
Lager für diesen Artikel ist begrenzt, kann aber in einem Lagerhaus in Ihrer Nähe zur Verfügung. Bitte stellen Sie sicher, dass Sie in sind angemeldet auf dieser Seite, so dass verfügbare Bestand angezeigt werden können. Wenn das call noch angezeigt wird und Sie Hilfe benötigen, rufen Sie uns an 1-800-932 - 5000.
Dieses Produkt kann nur an eine Lieferadresse versandt werden die über die entsprechende Lizenzen verfügt. Für weitere Hilfe bitte kontaktieren Sie Ihr VWR Vertriebszentrum.
-Additional Documentation May be needed to purchase this item. A VWR representative will contact you if needed.
Dieses Produkt wurde von Ihrer Organisation gesperrt, lassen Sie sich gegebenenfalls ein Angebot zum Artikel erstellen.
Bitte kontaktieren Sie Ihren Einkauf für weitere Informationen.
Dieses Produkt ist Ersatz für den von Ihnen gewünschten Artikel.
Der mit diesem Symbol gekennzeichnete Artikel wird aus dem Programm genommen. Er ist nur noch bis zum Ende des Lagerbestands verfügbar. Sicher haben wir aber eine Alternative im Sortiment. Bei der Suche unterstützen wir Sie gerne! Wenden Sie sich dafür einfach an Ihre Ansprechpartner im Customer Service, Ihren Account Manager, Ihren Produktspezialisten oder unter 06151/39720 an unsere Zentrale in Darmstadt.
1 - 16 of 46 154
no targeter for Bottom